Papers: 10.1128/AAC.01395-19
https://doi.org/10.1128/AAC.01395-19
Multiple-Ascending-Dose Phase 1 Clinical Study of the Safety, Tolerability, and Pharmacokinetics of CRS3123, a Narrow-Spectrum Agent with Minimal Disruption of Normal Gut Microbiota
Cited by: 11
Author(s): Barbara Lomeli, Hal Galbraith, Jared Schettler, George A. Saviolakis, Wael Elamin, Blaire L. Osborn, Jacques Ravel, Keith Z. Hazleton, Catherine Lozupone, Ronald J. Evans, Stacie Bell, Urs A. Ochsner, Thale C. Jarvis, Shahida Baqar, Nebojša Janjić
Published: over 6 years ago
Software Mentions 1
cran: PERMANOVA
Multivariate Analysis of Variance Based on Distances and PermutationsPapers that mentioned: 6,292
Very Likely Science (85)